TAMIFLU BUOYS SALES AT ROCHE

BASEL, Switzerland Strong demand for cancer medicines and the antiviral drug Tamiflu helped increase Roche Holding's first-quarter sales by 22 percent, the Swiss pharmaceutical company said Wednesday.

International Herald Tribune (http://www.iht.com/articles/2006/04/26/business/Roche.php)